The St. John's Morning Show

709 Roller Derby is ready for a knock down drag out evening tonight at the Mount Pearl Glacier. We sent the Morning Show's Katherine Crummey out to meet some of the toughest skaters in town.

In this edition of Chase the Seasons with Charlie, we'll learn how to camp with a low environmental impact mindset.

It's nearly fall, and children and teachers are heading back to their classrooms next week. We spoke with Chief Medical Officer of Health, Dr. Janice Fitzgerald, about this fall's Covid outlook.

Ahoy, Matey! The Serenade of the Seas arrived in St. John's yesterday. The Morning Show's Jessica Singer met some passengers on the waterfront.

The province wants to tighten rules around cell phones in the classroom, and a new personal electronic device policy will be drafted this fall. The CBC's Jenna Head brought us more on that story.

Something's building in Brigus. Randy Spracklin of Newfound Builders talked about the success of the renovation show Rock Solid Builds, and what to expect in season three.

Morning Show reporter Jessica Singer stopped by the Delta Hotel in downtown St. John's, where they're hosting a national conference that's connecting people living with scleroderma. She spoke with Jason Doucette and Jillian Penney-Turner. Jason is the president of Scleroderma Atlantic, and Jillian lives with scleroderma.

Ottawa is cutting down the number of temporary foreign workers in this country. Labour market researcher and Memorial University economics professor Tony Fang explained how that could affect this province's workforce.

Back to school time is expensive for everyone... and for single parent families, it can be a struggle to get kids everything they need. Allison Smith-Bungay is an Employment Services Specialist with the Single Parent Association. She gave us more info on their programs.

Doctors in seven countries have begun trials of a mRNA vaccine in patients. Instead of targeting a virus, this vaccine is intended to target cancer cells. The medical research is still at a very early stage. The trials, now underway, aim to treat lung cancer in about 130 patients. Our medical columnist, Doctor Peter Lin, joined us for more.